Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan D Sniderman

Showing results (71-80 of 164) with videos related to

Pageof 17
Sort By:
Journal of Clinical Lipidology|September 27, 2012
Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoproteinAllan D Sniderman, Andre Tremblay, Jacqueline De Graaf, et al.
The New England Journal of Medicine|July 3, 2014
Application of the new cholesterol guidelinesAnn Marie Navar-Boggan, Allan D Sniderman, Michael J Pencina
Journal of Clinical Lipidology|December 3, 2010
When is equal not equal?Allan D Sniderman, Ken Williams, Matthew J McQueen, et al.
Journal of Clinical Lipidology|September 29, 2016
An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoBAllan D Sniderman, Peter P Toth, George Thanassoulis, et al.
Atherosclerosis|April 22, 2014
Calculation of LDL apoBAllan D Sniderman, André J Tremblay, Jacqueline De Graaf, et al.
Journal of the American Heart Association|July 25, 2023
Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-CholesterolJohn H Contois, Michel R Langlois, Christa Cobbaert, et al.
Journal of Clinical Lipidology|December 3, 2010
Should we use apoB for risk assessment and as a target for treatment?W Virgil Brown, Gary L Myers, Allan D Sniderman, et al.
Diabetes Care|March 5, 2002
Hypertriglyceridemic hyperapoB in type 2 diabetesAllan D Sniderman, Benoit Lamarche, Jessica Tilley, et al.
Clinical Biochemistry|October 18, 2003
Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formulaAllan D Sniderman, David Blank, Robert Zakarian, et al.
Current Opinion in Lipidology|October 12, 2011
Should preclinical vascular abnormalities be measured in asymptomatic adults to improve cardiovascular risk stratification?Jacqueline de Graaf, Suzanne Holewijn, Anton F Stalenhoef, et al.
Pageof 17

Showing results (71-80 of 164) with videos related to

Sort By:
Pageof 17
Journal of Clinical Lipidology|September 27, 2012
Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoproteinAllan D Sniderman, Andre Tremblay, Jacqueline De Graaf, et al.
The New England Journal of Medicine|July 3, 2014
Application of the new cholesterol guidelinesAnn Marie Navar-Boggan, Allan D Sniderman, Michael J Pencina
Journal of Clinical Lipidology|December 3, 2010
When is equal not equal?Allan D Sniderman, Ken Williams, Matthew J McQueen, et al.
Journal of Clinical Lipidology|September 29, 2016
An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoBAllan D Sniderman, Peter P Toth, George Thanassoulis, et al.
Atherosclerosis|April 22, 2014
Calculation of LDL apoBAllan D Sniderman, André J Tremblay, Jacqueline De Graaf, et al.
Journal of the American Heart Association|July 25, 2023
Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-CholesterolJohn H Contois, Michel R Langlois, Christa Cobbaert, et al.
Journal of Clinical Lipidology|December 3, 2010
Should we use apoB for risk assessment and as a target for treatment?W Virgil Brown, Gary L Myers, Allan D Sniderman, et al.
Diabetes Care|March 5, 2002
Hypertriglyceridemic hyperapoB in type 2 diabetesAllan D Sniderman, Benoit Lamarche, Jessica Tilley, et al.
Clinical Biochemistry|October 18, 2003
Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formulaAllan D Sniderman, David Blank, Robert Zakarian, et al.
Current Opinion in Lipidology|October 12, 2011
Should preclinical vascular abnormalities be measured in asymptomatic adults to improve cardiovascular risk stratification?Jacqueline de Graaf, Suzanne Holewijn, Anton F Stalenhoef, et al.
Pageof 17